Resolutions of Lemminkäinen Corporation's Annual General

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Resolutions of Lemminkäinen Corporation's Annual General Meeting

LEMMINKÄINEN CORPORATION    STOCK EXCHANGE RELEASE   9 APRIL 2014 AT 4:45 P.M

RESOLUTIONS OF LEMMINKÄINEN CORPORATION'S ANNUAL GENERAL MEETING

On 9 April 2014, Lemminkäinen Corporation's Annual General Meeting adopted the Company's annual accounts and consolidated financial statements for 2013 and granted the members of the Board of Directors and the President and CEO discharge from liability.

Payment of dividend

The General Meeting resolved, in accordance with the Board of Directors' proposal, that no dividend be paid for the financial year ended 31 December 2013.

Board membership and remuneration

The General Meeting confirmed the number of members of the Board of Directors as six. Berndt Brunow, Noora Forstén, Finn Johnsson, Juhani Mäkinen, Kristina Pentti-von Walzel, and Heikki Räty were elected as members of the Board. The General Meeting confirmed that a remuneration of EUR 3,000 per month be paid to the members of the Board of Directors, EUR 10,000 per month be paid to the Chairman of the Board, and EUR 500 be paid in respect of each board meeting attended. It was further resolved that the Chairman of the Audit Committee be paid an attendance fee of EUR 1,000 and the members of the Audit Committee be paid an attendance fee of EUR 500 for each meeting of the Committee. In addition, it was resolved that the members residing abroad are to be paid the attendance fee increased by EUR 1,000. Travel expenses will be reimbursed as invoiced. Election of the auditor and audit fee PricewaterhouseCoopers Oy, a firm of authorised public accountants, was re-elected to serve as the Company's auditor. The audit fee will be paid as invoiced. Authorisation to repurchase the Company's own shares The General Meeting resolved, in accordance with the Board of Directors' proposal, to authorise the Board of Directors to resolve on the repurchase of the Company's own shares. In accordance with the authorisation, the Board of Directors may resolve to repurchase a maximum of 1,000,000 own shares in one or several instalments, using the unrestricted shareholders' equity of the Company, subject to the provisions of the Finnish Companies Act on the maximum amount of own shares in the possession of the Company or its subsidiaries. The Board of Directors may resolve to repurchase shares also in another proportion than in proportion to the holdings of shareholders. The shares shall be purchased in public trading at the prevailing market price. The purchases shall be carried out on NASDAQ OMX Helsinki Ltd. in accordance with its rules and regulations. The authorisation is effective for a period of 18 months from the resolution of the General Meeting. The previous authorisation granted to the Board of Directors regarding repurchase of own shares expired simultaneously. Authorisation of the Board of Directors to resolve on a share issue and an issue of special rights The General Meeting resolved, in accordance with the Board of Directors' proposal, to authorise the Board of Directors to resolve on a share issue and/or an issue of special rights entitling to shares referred to in Chapter 10, Section 1 of the Finnish Limited Liability Companies Act in one or several instalments, either against payment or without payment. The number of shares to be issued, including the shares to be received based on special rights, shall not exceed 3,900,000 shares. The maximum number corresponds to approximately 20 per cent of all the current shares of the Company. The Board of Directors may resolve to issue either new shares or own shares possibly held by the Company. The authorisation entitles the Board of Directors to resolve on all terms and conditions of the share issue and the issue of special rights entitling to shares, including the right to derogate from the pre-emptive right of the shareholders. The authorisation may be used for the financing or execution of any acquisitions or other business arrangements, to strengthen the balance sheet and financial position of the Company or for other purposes as determined by the Board of Directors. The authorisation is in force for a period of 18 months from the resolution of the General Meeting. The previous authorisation, granted to the Board of Directors regarding a share issue and an issue of special rights expired simultaneously. Minutes of the meeting The minutes of the General Meeting of shareholders will be available on Lemminkäinen's website as from 23 April 2014 at the latest. LEMMINKÄINEN CORPORATION Corporate Communications

ADDITIONAL INFORMATION: Senior Vice President, Legal Affairs Johan Nybergh tel. +358 2071 54811 johan.nybergh@lemminkainen.com  

DISTRIBUTION: NASDAQ OMX Helsinki Key media www.lemminkainen.com

Together with our customers we create conditions that make living, working and travelling functional, safe and healthy. We operate in northern Europe and employ about 7,800 experts. In 2013, our net sales were about EUR 2.2 billion. Lemminkäinen Corporation's share is quoted on NASDAQ OMX Nordic Exchange Helsinki. www.lemminkainen.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 72

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 587

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 116

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 133

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 563

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 222

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 169

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 251

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 424

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 337

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading

Top 5 Most Recently Viewed Articles

Unlocking Interoperability: The Free Partner Edition by interop.io

Updated Category News Views 230

Unlocking New Potential in Fintech with Free Edition interop.io, known as a frontrunner in desktop interoperability, is set to revolutionize the way fintech companies operate with the introduction of a cost-free edition of their software suite, named io.Connect. This new initiative aims to provide fintechs, regardless of their size or stage, with the opportunity to adopt...

Continue Reading
Massage Envy Celebrates Scholarship Winners and Their Future

Updated Category News Views 164

Massage Envy Celebrates Scholarship Winners Eight outstanding individuals have been recognized as winners of the Massage Envy National Scholarship Sweepstakes, each receiving a $2,500 scholarship to support their journey into the massage therapy profession. This initiative demonstrates Massage Envy's commitment to fostering the next generation of talented massage...

Continue Reading
Paul Mueller Company Updates Investors on Dividend Plans

Updated Category News Views 397

Paul Mueller Company Declares Cash Dividend Paul Mueller Company (OTC: MUEL) has some exciting news for its investors. The company has recently announced that its Board of Directors has declared a cash dividend of $0.30 per share on its outstanding common stock. This dividend reflects the company’s ongoing commitment to providing value to its shareholders. Details of...

Continue Reading
Photocure Enhances Leadership with Jane Healy as GM EMEA

Updated Category News Views 360

Photocure Welcomes Jane Healy as Vice President and General Manager EMEA Photocure ASA (OSE: PHO), known as the Bladder Cancer Company, has made a significant move by appointing Jane Healy as the new Vice President and General Manager for the EMEA region. This strategic decision underscores Photocure's commitment to enhancing its leadership in the uro-oncology sector....

Continue Reading
TDS Hits Bumps but Keeps Shareholders Happy

Updated Category News Views 48

High Hopes and Hard Hits: TDS in 2026 Listen up, folks. Telephone and Data Systems, Inc. (NYSE: TDS) just popped the hood on their third quarter earnings, and it's a mixed bag with plenty to chew over. Operating revenues are slightly down from last year, but management's got some tricks up their sleeves. CEO Walter Carlson is trumpeting their expanded fiber service...

Continue Reading